| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.00078 | 1 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.00071 | 1 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | 0.0035 | 1 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.0008 | 1 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.00071 | 1 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | 0.0036 | 1 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | -0.00071 | 1 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.00068 | 1 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.00089 | 1 |